vs

Side-by-side financial comparison of Ecolab (ECL) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $4.1B, roughly 1.1× Ecolab). Emerson Electric runs the higher net margin — 13.9% vs 10.6%, a 3.3% gap on every dollar of revenue. On growth, Ecolab posted the faster year-over-year revenue change (10.0% vs 4.1%). Over the past eight quarters, Ecolab's revenue compounded faster (1.0% CAGR vs -0.3%).

Ecolab Inc., headquartered in Saint Paul, Minnesota, provides products related to water treatment, sanitation, and hygiene, primarily to commercial and industrial customers.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

ECL vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.1× larger
EMR
$4.3B
$4.1B
ECL
Growing faster (revenue YoY)
ECL
ECL
+5.9% gap
ECL
10.0%
4.1%
EMR
Higher net margin
EMR
EMR
3.3% more per $
EMR
13.9%
10.6%
ECL
Faster 2-yr revenue CAGR
ECL
ECL
Annualised
ECL
1.0%
-0.3%
EMR

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
ECL
ECL
EMR
EMR
Revenue
$4.1B
$4.3B
Net Profit
$432.6M
$605.0M
Gross Margin
53.2%
Operating Margin
15.3%
17.8%
Net Margin
10.6%
13.9%
Revenue YoY
10.0%
4.1%
Net Profit YoY
1.3%
3.4%
EPS (diluted)
$1.52
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECL
ECL
EMR
EMR
Q2 26
$4.1B
Q4 25
$4.2B
$4.3B
Q3 25
$4.2B
$4.9B
Q2 25
$4.0B
$4.6B
Q1 25
$3.7B
$4.4B
Q4 24
$4.0B
$4.2B
Q3 24
$4.0B
$4.6B
Q2 24
$4.0B
$4.4B
Net Profit
ECL
ECL
EMR
EMR
Q2 26
$432.6M
Q4 25
$563.9M
$605.0M
Q3 25
$585.0M
$637.0M
Q2 25
$524.2M
$586.0M
Q1 25
$402.5M
$485.0M
Q4 24
$472.9M
$585.0M
Q3 24
$736.5M
$996.0M
Q2 24
$490.9M
$329.0M
Gross Margin
ECL
ECL
EMR
EMR
Q2 26
Q4 25
44.0%
53.2%
Q3 25
44.8%
51.9%
Q2 25
44.8%
52.6%
Q1 25
44.2%
53.5%
Q4 24
43.3%
53.5%
Q3 24
43.4%
51.3%
Q2 24
43.8%
52.8%
Operating Margin
ECL
ECL
EMR
EMR
Q2 26
15.3%
Q4 25
17.0%
17.8%
Q3 25
18.3%
16.4%
Q2 25
17.6%
16.1%
Q1 25
15.0%
14.2%
Q4 24
14.6%
18.6%
Q3 24
26.1%
14.7%
Q2 24
16.5%
10.4%
Net Margin
ECL
ECL
EMR
EMR
Q2 26
10.6%
Q4 25
13.4%
13.9%
Q3 25
14.0%
13.1%
Q2 25
13.0%
12.9%
Q1 25
10.9%
10.9%
Q4 24
11.8%
14.0%
Q3 24
18.4%
21.6%
Q2 24
12.3%
7.5%
EPS (diluted)
ECL
ECL
EMR
EMR
Q2 26
$1.52
Q4 25
$1.98
$1.07
Q3 25
$2.05
$1.12
Q2 25
$1.84
$1.04
Q1 25
$1.41
$0.86
Q4 24
$1.65
$1.02
Q3 24
$2.58
$1.74
Q2 24
$1.71
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECL
ECL
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$519.8K
Total DebtLower is stronger
$8.5M
$7.6B
Stockholders' EquityBook value
$10.0M
$20.3B
Total Assets
$25.0M
$41.9B
Debt / EquityLower = less leverage
0.85×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECL
ECL
EMR
EMR
Q2 26
$519.8K
Q4 25
$646.2M
Q3 25
$2.0B
Q2 25
$1.9B
Q1 25
$1.2B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$384.0M
Total Debt
ECL
ECL
EMR
EMR
Q2 26
$8.5M
Q4 25
$7.4B
$7.6B
Q3 25
$8.1B
$8.9B
Q2 25
$7.5B
$8.3B
Q1 25
$7.0B
$8.2B
Q4 24
$6.9B
$6.6B
Q3 24
$7.0B
$7.7B
Q2 24
$7.5B
$7.1B
Stockholders' Equity
ECL
ECL
EMR
EMR
Q2 26
$10.0M
Q4 25
$9.8B
$20.3B
Q3 25
$9.7B
$20.3B
Q2 25
$9.3B
$19.9B
Q1 25
$8.9B
$19.2B
Q4 24
$8.8B
$20.5B
Q3 24
$8.5B
$21.6B
Q2 24
$8.3B
$20.8B
Total Assets
ECL
ECL
EMR
EMR
Q2 26
$25.0M
Q4 25
$24.7B
$41.9B
Q3 25
$23.9B
$42.0B
Q2 25
$23.7B
$42.5B
Q1 25
$22.4B
$42.0B
Q4 24
$22.4B
$42.6B
Q3 24
$22.1B
$44.2B
Q2 24
$21.5B
$45.6B
Debt / Equity
ECL
ECL
EMR
EMR
Q2 26
0.85×
Q4 25
0.75×
0.37×
Q3 25
0.83×
0.44×
Q2 25
0.81×
0.42×
Q1 25
0.79×
0.42×
Q4 24
0.79×
0.32×
Q3 24
0.82×
0.36×
Q2 24
0.91×
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECL
ECL
EMR
EMR
Operating Cash FlowLast quarter
$699.0M
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECL
ECL
EMR
EMR
Q2 26
Q4 25
$1.1B
$699.0M
Q3 25
$791.3M
$3.1B
Q2 25
$701.8M
$1.1B
Q1 25
$369.4M
$241.0M
Q4 24
$766.7M
$777.0M
Q3 24
$786.7M
$3.3B
Q2 24
$611.1M
$1.1B
Free Cash Flow
ECL
ECL
EMR
EMR
Q2 26
Q4 25
$758.0M
$602.0M
Q3 25
$529.7M
$2.7B
Q2 25
$485.1M
$977.0M
Q1 25
$131.5M
$154.0M
Q4 24
$407.0M
$694.0M
Q3 24
$550.3M
$2.9B
Q2 24
$414.2M
$998.0M
FCF Margin
ECL
ECL
EMR
EMR
Q2 26
Q4 25
18.1%
13.9%
Q3 25
12.7%
54.9%
Q2 25
12.1%
21.5%
Q1 25
3.6%
3.5%
Q4 24
10.2%
16.6%
Q3 24
13.8%
63.1%
Q2 24
10.4%
22.8%
Capex Intensity
ECL
ECL
EMR
EMR
Q2 26
Q4 25
7.9%
2.2%
Q3 25
6.3%
8.9%
Q2 25
5.4%
2.0%
Q1 25
6.4%
2.0%
Q4 24
9.0%
2.0%
Q3 24
5.9%
9.1%
Q2 24
4.9%
2.1%
Cash Conversion
ECL
ECL
EMR
EMR
Q2 26
Q4 25
1.93×
1.16×
Q3 25
1.35×
4.86×
Q2 25
1.34×
1.83×
Q1 25
0.92×
0.50×
Q4 24
1.62×
1.33×
Q3 24
1.07×
3.35×
Q2 24
1.24×
3.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECL
ECL

Product and equipment sales$3.2B78%
Service and lease sales$891.5M22%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons